Pharmacokinetics and Pharmacodynamics of the Nitroimidazole DNDI-0690 in Mouse Models of Cutaneous Leishmaniasis

The nitroimidazole DNDI-0690 is a clinical drug candidate for visceral leishmaniasis (VL) that also shows potent in vitro and in vivo activity against cutaneous leishmaniasis (CL). To support further development of this compound into a patient-friendly oral or topical formulation for the treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wijnant, Gert-Jan, Croft, Simon L., de la Flor, Raul, Alavijeh, Mo, Yardley, Vanessa, Braillard, Stéphanie, Mowbray, Charles, Van Bocxlaer, Katrien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709472/
https://www.ncbi.nlm.nih.gov/pubmed/31262757
http://dx.doi.org/10.1128/AAC.00829-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709472/
https://www.ncbi.nlm.nih.gov/pubmed/31262757
http://dx.doi.org/10.1128/AAC.00829-19

Ejemplares similares